Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
eIF2C1 CRISPR Activation Plasmid (m): sc-437349-ACT
- Target species: mouse
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- eIF2C1 CRISPR Activation Plasmid (m) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- eIF2C1 CRISPR Activation Plasmid (m) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- gRNAs encoded by eIF2C1 CRISPR Activation Plasmid (m) and eIF2C1 CRISPR Activation Plasmid (m2) target distinct regulatory regions upstream of the Ago1 transcriptional start site. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
eIF2C1 CRISPR Activation Plasmid (m) | sc-437349-ACT | 20 µg | $397.00 | |||
eIF2C1 CRISPR Activation Plasmid (m2) | sc-437349-ACT-2 | 20 µg | $397.00 |
Mouse Ago1 encodes eIF2C1, an Argonaute family protein that binds small RNAs and serves as a core effector of RNA interference. eIF2C1 participates in miRNA- and siRNA-guided post-transcriptional gene silencing, influencing mRNA stability and translation and shaping gene expression programs linked to differentiation, proliferation, and stress responses. Through interactions within the RISC complex and related small RNA pathways, Ago1 contributes to epigenetic and transcriptional regulation in multiple tissues. Dysregulation of Argonaute-dependent small RNA networks has been associated with altered immune signaling, neurodevelopmental phenotypes, and oncogenic transcriptional states, making Ago1 a relevant node for mechanistic studies of gene regulatory circuitry.
eIF2C1 CRISPR Activation Plasmid (m) provides a targeted, non-destructive approach to upregulating endogenous Ago1 expression without altering the underlying DNA sequence.
eIF2C1 CRISPR Activation Plasmid (m) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the Ago1 locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the Ago1 transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous eIF2C1 expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native Ago1 locus and enabling the study of eIF2C1-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of eIF2C1 pathway restoration in tumor cells with silenced or reduced Ago1 expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.